title: Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgRKTto the List.
authors.affiliation: From the Department of Medicine, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism (P.L.S.M.G.), University of California San Diego, La Jolla.
authors.forename: Calvin
authors.initials: C
authors.lastname: Yeang
authors.affiliation: From the Department of Medicine, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism (P.L.S.M.G.), University of California San Diego, La Jolla.
authors.forename: Philip L S M
authors.initials: PL
authors.lastname: Gordts
authors.affiliation: From the Department of Medicine, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism (P.L.S.M.G.), University of California San Diego, La Jolla. stsimikas@ucsd.edu.
authors.forename: Sotirios
authors.initials: S
authors.lastname: Tsimikas
mesh_terms: D001054:Apolipoproteins A; D053241:Apoprotein(a); D004705:Endocytosis; D017270:Lipoprotein(a); D010958:Plasminogen
chemical_list: D001054:Apolipoproteins A; D017270:Lipoprotein(a); D010958:Plasminogen; D053241:Apoprotein(a)
keywords: Editorials; LDL receptor; PCSK9; aortic valve stenosis; lipoprotein(a); plasminogen